نتایج جستجو برای: attenuated vaccine

تعداد نتایج: 166073  

2016
Hanna Nohynek Ulrike Baum Ritva Syrjänen Niina Ikonen Jonas Sundman Jukka Jokinen

Although widely recommended, influenza vaccination of children is part of the national vaccination programme only in few countries. In addition to Canada and the United States (US), in Europe Finland and the United Kingdom have introduced live attenuated influenza vaccine (LAIV) for healthy children in their programmes. On 22 June 2016, the US Advisory Committee on Immunizations Practices, vote...

2011
Christopher S Ambrose Myron J Levin Robert B Belshe

In the United States, two types of vaccines are recommended for the prevention of influenza: an intranasal live attenuated influenza vaccine (LAIV) for eligible individuals aged 2-49 years and unadjuvanted injectable trivalent inactivated vaccines (TIV) for eligible individuals aged ≥ 6 months. Several recent studies have compared the efficacy of the 2 vaccines in children and adults. In childr...

Journal: :The Journal of infectious diseases 2006
John J Treanor Gilbert M Schiff Robert B Couch Thomas R Cate Rebecca C Brady C Mhorag Hay Mark Wolff Dewei She Manon M J Cox

BACKGROUND Influenza-virus hemagglutinin (HA) protein expressed in insect cells by recombinant baculovirus is a candidate influenza vaccine. METHODS In a randomized, double-blind trial conducted in 399 adults > or = 65 years of age, the efficacy of trivalent inactivated influenza vaccine (TIV) licensed for intramuscular injection was compared with that of trivalent baculovirus-expressed HA va...

Journal: :The Journal of infectious diseases 2014
Irina Tretyakova Jason Hearn Eryu Wang Scott Weaver Peter Pushko

BACKGROUND Chikungunya virus (CHIKV) causes outbreaks of chikungunya fever worldwide and represents an emerging pandemic threat. Vaccine development against CHIKV has proved challenging. Currently there is no approved vaccine or specific therapy for the disease. METHODS To develop novel experimental CHIKV vaccine, we used novel immunization DNA (iDNA) infectious clone technology, which combin...

Journal: :Vaccine 2013
Brendan Klick Sunita Durrani Kwok-Hung Chan Dennis K M Ip Erica S K Chou Henry K H Kwok Sophia Ng Susan S Chiu J S Malik Peiris Gabriel M Leung Benjamin J Cowling

BACKGROUND The novel influenza A(H1N1pdm09) virus emerged in North America in early 2009 and rapidly spread worldwide. In this study we report the efficacy of the live attenuated monovalent H1N1pdm09 vaccine and 2009-10 seasonal influenza vaccine in a randomized double-blind placebo-controlled trial. METHODS We enrolled 703 children aged 7-11. Each child was randomly allocated in the ratio 3:...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید